NASDAQ: ARTVArtiva Biotherapeutics Inc Stock Ownership - Who owns Artiva Biotherapeutics?
Insider buying vs selling
Have Artiva Biotherapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Fred Aslan | President and CEO | 2025-12-15 | 3,187 | $6.00 | $19.12kSell |
| Fred Aslan | President and CEO | 2025-11-17 | 6,375 | $3.38 | $21.52kSell |
| Heather Raymon | SVP Research and Development | 2025-11-15 | 1,375 | $3.25 | $4.47kSell |
| Fred Aslan | President and CEO | 2025-11-15 | 6,347 | $3.25 | $20.63kSell |
| Jennifer Bush | COO CLO Secy Compliance Off | 2025-11-15 | 3,055 | $3.25 | $9.93kSell |
| Christopher Horan | Chief Tech Operations Officer | 2025-11-15 | 1,899 | $3.25 | $6.17kSell |
| Neha Krishnamohan | Chief Financial Officer | 2025-11-15 | 3,490 | $3.25 | $11.34kSell |
| Fred Aslan | President and CEO | 2025-10-17 | 25,500 | $6.00 | $153.00kSell |
| Christopher Horan | Chief Tech Operations Officer | 2025-08-15 | 3,577 | $2.75 | $9.84kSell |
| Neha Krishnamohan | Chief Financial Officer | 2025-08-15 | 5,813 | $2.75 | $15.99kSell |
ARTV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ARTV insiders and whales buy or sell their stock.
ARTV Shareholders
What type of owners hold Artiva Biotherapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ra Capital Management LP | 40.14% | 9,853,302 | $47.79M | Institution |
| Yongjun Huh | 20.03% | 4,916,249 | $23.84M | Insider |
| Gc Corp | 18.61% | 4,567,412 | $22.15M | Insider |
| 5am Partners VI LLC | 9.59% | 2,353,304 | $11.41M | Insider |
| 5am Venture Management LLC | 9.59% | 2,353,304 | $11.41M | Institution |
| Venbio Global Strategic Fund III LP | 7.89% | 1,936,637 | $9.39M | Insider |
| Vr Adviser LLC | 6.56% | 1,609,569 | $7.81M | Institution |
| Fred Aslan | 4.93% | 1,209,948 | $5.87M | Insider |
| Venbio Partners LLC | 4.68% | 1,148,975 | $5.57M | Institution |
| Ra Capital Management LP | 3.37% | 826,832 | $4.01M | Insider |
ARTV vs Biotech Stocks
Artiva Biotherapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.